A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind (Investigator and subject-blinded) placebo-controlled,
multiple, ascending-dose study to evaluate the safety, tolerability, and pharmacokinetic
profile of BPN14770 in healthy young and elderly male and female subjects and to provide a
preliminary assessment of the cognitive effects of BPN14770 in healthy elderly subjects.